Pfizer to acquire skin specialist firm Excaliard
November 28, 2011Sales and Marketing EXC 001, Excaliard, Pfizer
Pfizer will acquire skin specialist Excaliard Pharmaceuticals as the firm looks to further diversify its pipeline. Financial terms of the …
Shire facility could answer rare disease drug shortage
November 27, 2011Manufacturing and Production Fabry disease, Gaucher, Shire, Vpriv
Shire has filed applications with the European and US regulators to produce its Gaucher disease drug Vpriv (velaglucerase alfa) at …
Pfizer’s Loughbeg first pharma facility to meet green standard
November 27, 2011Manufacturing and Production ISO 50001, Loughbeg, Pfizer, environmental
A Pfizer facility in Ireland has become the first pharmaceutical plant in the world to meet a tough new standard …
The changing of the guard – Q3 round up
November 25, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lipitor, Q3, Ranbaxy
PfizerOf all the patent cliffs in pharma, Lipitor’s expiry represents the biggest. Pfizer is now staring over the precipice, with …
Quality fears prompt cancer drug recalls
November 25, 2011Manufacturing and Production Ben Venue, EU, Hong Kong, manufacturing
Regulatory authorities around the world are recalling cancer drugs manufactured by Boehringer Ingelheim’s Ben Venue Laboratories subsidiary after an inspection …
Mixed results for UK in international health survey
November 25, 2011Sales and Marketing NHS, OECD, healthcare
The NHS in England does not perform well on some patient outcomes for cancer, stroke and respiratory diseases given the …
NICE okays Eliquis for blood clots after surgery
November 25, 2011Research and Development, Sales and Marketing BMS, Eliquis, NICE, Pfizer
NICE is recommending Pfizer and Bristol-Myers Squibb’s Eliquis for blood clots after surgery. Specifically, NICE has said that Eliquis (apixaban) …
RSA announces raft of new appointments
November 24, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
RSA, the global life sciences executive search and interim management firm, has announced a series of new appointments. RSA Switzerland …
Adaptive Trial Design
November 24, 2011Research and Development
Despite the burgeoning interest in Adaptive Trial Design (ATD), an extremely powerful tool when used effectively in the appropriate circumstances, …
Glyn Edwards appointed interim chief executive of the BioIndustry Association
November 24, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Glyn Edwards
The BioIndustry Association (BIA) has appointed Glyn Edwards as its interim chief executive effective immediately. Edwards was previously chief executive …
Lucentis not backed by NICE for new licence
November 24, 2011Sales and Marketing Lucentis, NICE, Novartis, Ozurdex
NICE has not recommended Novartis’ eye disease drug Lucentis due to ‘gaps and uncertainties’ in the manufacturer’s submission. In draft …
Professor Sir Michael Rawlins reappointed as NICE chairman
November 24, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, Rawlins
The National Institute for Health and Clinical Excellence (NICE) has reappointed Professor Sir Michael Rawlins as NICE chairman for a …
Private sector role in NHS commissioning opposed
November 23, 2011Medical Communications, Sales and Marketing BMA, CCGs, NHS, PCT clusters
Private firms could be allowed to support clinical commissioning groups, the new NHS budget holders in England.New draft guidance from the Department …
Future of public health uncertain, says Forum
November 23, 2011Sales and Marketing Future Forum, NHS, NHS reforms
The Department of Health has been urged to clarify the NHS’s responsibilities in relation to public health.The independent NHS Future …
Red Door launches Grapevine ‘localisation’ service
November 23, 2011Medical Communications Grapevine, Red Door
Red Door Communications has launched Grapevine – a new healthcare ‘localisation’ initiative and appointed Alasdair Williams as its head. Grapevine …
Pfizer hatches mail order plan for Lipitor
November 23, 2011Sales and Marketing Lipitor, Pfizer, US, generics
Pfizer is preparing to launch a new mail order service offering cut-price Lipitor direct to patients in the US.The firm …
Big pharma counts cost of R&D decline
November 23, 2011Research and Development Deloitte, GSK, IIR, R&D productivity
Leading pharma firms are getting around 30% less on their investments in research and development compared to last year, according …
Merck pays $950 million to settle Vioxx charges
November 23, 2011Sales and Marketing Department of Justice, Merck, Vioxx, marketing violations, off label marketing
Merck will pay out $950 million and admit that it illegally marketed its painkiller Vioxx in the US. It will …
Pharmalink elects Anders Wiklund as its new board chairman
November 23, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Pharmalink
Swedish speciality firm Pharmalink AB has elected Anders Wiklund to serve as its new chairman of the board. In addition …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
